## ## ## ## ## ## ## ## ## ## |The Trust is delighted
to be working|with the following 41organisations,|with the following 41organisations,|who have|sponsored|sponsored|the Fellows in| |---|---|---|---|---|---|---| |post during the last financial year, many ofthem fully||or part sponsoring|more than|one Fellow:||| |Animal
Free Research||The Nutrition|Society|||| |Babraham
Institute||Queen
Mary|University ofLondon|||| |Biotechnology
and Biological Sciences Research||Royal Academy of Engineering||||| |Council||Royal Society ofChemistry||||| |British Heart Foundation||Science and Technology||Facilities|Council|| |Brunel University||Society for Chemicallndustry||||| |Ceramysis||Swansea
University||||| |Durham
University||University
College London||||| |Economic and Social Research Council||University
of|Birmingham|||| |Elizabeth
Blackwell Institute for Health Research||University
of|Central
Lancashire|||| |Engineering
and Physical Sciences Research||University
of|East Anglia|||| |Council||University of|Edinburgh|||| |Genesis Research Trust||University
of|Huddersfield|||| |Imperial
College London||University
of|Leeds|||| |Institute ofCancer Research||University
of|Leicester|||| |John Innes Centre||University
of|Liverpool|||| |The Kennedy Trust||The University|ofManchester|||| |Kidney Research
UK||The University|of Nottingham|||| |Medical Research Council
Medica I Resea rch Scotia nd||University
of
University
of|Strathclyde
Surrey|||| |Natio na I Phys ica I labora tory||University
of|York|||| |Natural
Environment
Research Council||||||| ## ## |Alan Turing Institute||Medical|Research Council| |---|---|---|---| |Arts and Humanities|Research Council|Medica
I|Research Scotland| |Biotechnology
and Biological Sciences Research||Natural
Environment
Research Council|| |Council||Royal Academy of Engineering|| |British Heart Foundation||Royal Society ofChemistry|| |Durham
University||Science and Technology
Facilities Council|| |Economic and Social|Research Council|University|of Leicester| |Engineering
and Physical Sciences Research||University|of Nottingham| |Council||University|ofOxford| |Imperial
College London||University|ofSurrey| |John Innes Centre||University|ofYork| |Kidney Research
UK|||| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |REFERENCE|AND ADMINISTRA|TIVE
DETAILS (continued|TIVE
DETAILS (continued|)|| |---|---|---|---|---|---| |Professional|Advisors:|Ellis Whittam||Limited|| |||Woodhouse|||| |||Aldford|||| |||Chester|||| |||Cheshire|||| |||CH3 6JD|||| |Auditors:||Knox Cropper||LLP|| |||Office Suite|1||| |||Haslemere|House||| |||Lower Street|||| |||Hasle mere|||| |||Surrey|||| |||GU27 2PE|||| |Bankers:||National
Westminster|||Bank pic| |||PO Box236|||| |||University
ofSurrey|||| |||Guildford|||| |||Surrey|||| |||GU2 5ZX|||| |Solicitors:||Barlow Robbins|||| |||The Oriel|||| |||Sydenham
Road|||| |||Guildford|||| |||Surrey|||| |||GU1 3SR|||| ## ## ## ## ## ## ## ## ## ## ## ## |||||(0 '5
C
0 ~
I-4|(0 '5
C
0 ~
I-4|W|CO
pv
N
Cho|R
o
00|Chooo||00
LD
oo||||CO
oo|00
tel
IV
Ch||CO
(VI
PV
Ch||tvlct
LO
CO
Ol|CQo|| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| |||||'0
'pm
r C
V
Ill4
QI||W|00
LD
oo|I|00
oo||oo
LD|||I|oo
LO|Ch
ftl
tt)|00oo
CO|M
Ch
Ul||Ch
00||| |||||'0
Qi
L
VI
Ql|0C
4|W|o
4&
'Ci'
fV
CO|+
o
00
LO|tV
Ch
CO||||||||00oo
00
IV|Ul
00||Ol
CV|o
00
Ch|| |I||||CD||||||||||||||||||| |CC:I-
Z|Ul
I-|o
E4||tQ
+'
0
I-|~
CW
~
4||Ol M
(tl 00
O (Y)
Ul ttl
CO||o
lV
CO
00||Choo||I||Choo|(Y)
cf
ttl||ttl
ttl||Ch
COo|CV
fV
LD
Ul|| |0|6|||||||||||||||||||||| |OC0|UZ
Z|0Z
XI-
i'
O|o
(4o
CV|'0
'I
+J
Q(
Ml|CW||LD
Ul
Ch|I|ct'
Lfi
Ch||lVo
Ul
Ol||||CVo
Ul
Ol|(4o
Ul
CVo
LO|Ul
Ul
(V)|Lfl
Ol
lfl
fV|||CV
Ch
'IQ'oo|| |Z0
hC
CJ
ZZ
CL|0I-Z
I-
I-|QZ
OC
ZI-
0||CL
'0
QJ
0
v CW
(A
Qi4
C|||h
CQ
00||Ul
COo
Ch||00
00
Ul
lY)|I|||Ul
00
00
Ul
t(l|Olo
Ul
CV|Lfl
Lfl
LO
Ch|00
tV
Lfi
PV||lVo
CO
Ch(4
tV)|o
Ltl
'CP|| |Ci||||||||||||||||||||||| |ZI-|||||I0Z|||||||||||||||||QI| |||||||||||||||||||||||00| |||||||||||||||||||||||C0o| |||||||||||||||||||||||E0| |||||||||||||||||||||||II| |||||||||||||||||||||||QI| |||||||||||||||||||||||I| |||||||||||||||||QlL|||4Z|(C|'0|Q7
QJ| |||||||0
CC
0
Z|O
Ql
0 o
ac
+
C C
m"
~E
+J
N
(0
Q'||(LI
E0
C
(0
0I-|Z~
I
QI
QUJ'~4
(0
QI
O~ x
Zv
I
(0
Lu'I e
CL
(0 M
Xw ~
LU M0|||||(0
0C
(0
CLx
Ql
(((
0I-|'0
C
(0
CLxII
E0
CIZ|II
C
QI
(LI
QJ
12
I-|If(
Cv
QI
QfZ|440
QI-c(
U
0
CC|00
0
'0
C
(00I-|0
Q(
'D
C
(0
0I-|(C
(LI
L
Ql
0
(0
(U
0| ## ## ## |||2020|2019| |---|---|---|---| ||Notes||| |CASH FLOWS FROM OPERATING|||| |ACTIVITIES|||| |Net cash used in/(provided
by) in operating|||| |activities||707,128|103,325| |CASH FLOWS FROM INVESTING ACTIVITIES|||| |Bank Interest
Purchase ofTangible
Fixed Assets||3,381
(2,936)|6,801| |Net cash provided
by investment
activities||445|6,801| |CHANGE
IN CASH AND CASH EQUIVALENTS|||| |IN THE FINANCIAL YEAR||707,573|110,126| |Cash and Cash Equivalents
at the beginning|||| |ofthe fina ncia
I yea r||1,517,461|1,407,335| |Cash and Cash Equivalents
at the end|||| |ofthe fina ncia
I yea r||E2,225,034|E1,517,461| |NOTES TO THE STATEMENT OF
CASH FLOWS
A)
Reconciliation
of Net Expenditure
to Net|Cash Flow from|2020
f|2019
f| |Operating
Activities|||| |Net Income to Net Cash Flow|||| |From Operating
Activities|||| |Net Income for the Financial Year
Adjustments
for
-
Depreciation||377,473
1,031|92,348
71| |Bank Interest received
(increase)/Decrease
in Debtors
Increase
in Creditors||(3,381)
(118,405)
450,410|(6,801)
6,881
10,826| |Net cash used in/(provided
by) Operating|Activities|E707,128|f103,325| |B)
Analysis of Cash and Cash Equivalent|||| |Bank Current Accounts
Bank Deposit Accounts||1,275,034
950,000|567,461
950,000| |||E2,225,034|E1,517,461| ## ## ## ## ## ## ## ## ## ## ## ## |||||2020|||2019| |---|---|---|---|---|---|---|---| ||||Unrestricted|Restricted||Total|Total| ||||Funds|Funds||Funds|Funds| |2.|GRANTS AND DONATIONS|||f|||f| ||Donations
Grants||87,475|1,297,564||87,475
1,297,564|103,260
989,968| ||||f87,475|f1,297,564||f1,385,039|f1,093,228| |3,|INVESTMENT INCOME||||||| ||Bank interest||f3,381|f|-|f3,381|f6,801| |4.|RESOURCES EXPENDED ON||||||| ||CHARITABLE ACTIVITIES||||||| ||Grants payable —Fellowship
Support costs rsee note 5)|Payments|3,568
312,317|695,062||698,630
312,317|665,948
341,733| ||||f315,885|f695,062||f1,010,947|f1,007,681| ## |||||||2020|2019| |---|---|---|---|---|---|---|---| ||||Unrestricted|Restricted||Total|Total| ||||Funds|Funds||Funds|Funds| ||||f|f||f|f| |5,|SUPPORT COSTS||||||| ||Administrative
support||245,498|||245,498|230,188| ||Rent, light and heat||20,000|||20,000|20,000| ||Bank charges||302|||302|390| ||Telephone||991|||991|998| ||Printing,
postage and stationery||4,631|||4,631|5,696| ||Depreciation||1,031|||1,031|71| ||Insurance||1,520|||1,520|1,415| ||Lega
I and professional|fees|4,123|||4,123|4,320| ||Trust development||11,889|||11,889|12,539| ||Meetings
and expenses||6,129|||6,129|17,058| ||Subscriptions
and publicity||1,725|||1,725|1,272| ||Website costs||1,098|||1,098|| ||Staff training||608|||608|1,458| ||Sundry expenditure||3,896|||3,896|2,230| ||Daphne Jackson Trust Conference||||||34,014| ||Auditors'
remuneration|—Audit|6,600|||6,600|6,360| ||Trustees and Committee||||||| ||Members costs||2,276|||2,276|3,724| ||||f312,317|f|-|f312,317|f341,733| |6.|NET INCOME||||||| ||ISSTATED AFTER CHARGING||||||| ||Auditors'
remuneration|—Audit|6,600|||6,600|6,360| ||Depreciation||1,031|||1,031|71| ## |||||||2020|||2019||| |---|---|---|---|---|---|---|---|---|---|---|---| |||||||Total Funds
f|||Total Funds||| |Gross wages||||||224,931|||211,157||| |Employer's|national||insurance||costs|13,852|||13,237||| |Pension contributions||||||6,715|||5,794||| |||||||E245,498|||2230,188||| ||||||||2020|||2019|| |The average||number|ofemployees,|||No.||FTE|No.||FTE| |analysed
by|function||was;||||||||| |Administration||ofcharitable||activities||||7|11||| ## ## ## |FIXED ASSETS|||Computer|Office|| |---|---|---|---|---|---| ||||Equipment|Equipment
f|Total
E| |Cost|||||| |At 1st December 2019
Additions|||11,001|1,735|12,736| |At 30th November
2020|||2,936||2,936| ||||13,937|1,735|15,672| |Accumulated|Depreciation||||| |At 1st December 2019
Charge for the year|||10,994
978|1,542
53|12,536
1,031| |At 30th November
2020|||11,972|1,595|13,567| |Net book value|at 30th November|2020|E1,965|f140|E2,105| |Net book value|at 30th November|2019|E7|f193|E200| ## ## ## ## ## ## ## |2020||Total funds|||Transfers|Total funds| |---|---|---|---|---|---|---| |||brought|Total|Total|between|carried| |||forward|Income|Expenditure|funds|forward| |Restricted funds||||||| |Grants payable to||748,977|1,297,564|(695,062)|(346,557)|1,004,922| |Fellows||||||| |Unrestricted|funds|||||| |General fund||329,802|90,856|(315,885)|346,557|451,330| |Total funds||E1,078,779|E1,388,420|E(1,010,947)|E
-|E1,456,252| |2019||Total funds|||Transfers|Total funds| |||brought|Total|Total|between|carried| |||forward|Income|Expenditure|funds|forward| |||||E|f|| |Restricted funds||||||| |Grants payable to||689,314|1,010,768|(671,007)|(280,098)|748,977| |Fellows||||||| |Unrestricted|funds|||||| |General fund||297,117|89,261|(336,674)|280,098|329,802| |Tota I funds||E986,431|E1,100,029|E(1,007,681)|E
-|E1,078,779| ##